COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)

COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd) (real clinical drug)

active
Code39114911000001105
Semantic tagreal clinical drug
Moduleuk-clinical
Definitiondefined
Effective time20260506

Parents (2)

Children (0)

None (leaf concept).